Pinnacle Associates LTD Cara Therapeutics, Inc. Transaction History

Pinnacle Associates LTD

  • $6.3 Billion
  • Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 11,727 shares of CARA stock, worth $3,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,727
Previous 57,350 79.55%
Holding current value
$3,635
Previous $14,000 78.57%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$0.26 - $0.38 $11,861 - $17,336
-45,623 Reduced 79.55%
11,727 $3,000
Q2 2024

Jul 30, 2024
BUY
$0.24 - $0.92 $13,764 - $52,762
57,350 New
57,350 $14,000
Q4 2023

Jan 19, 2024
SELL
$0.6 - $1.65 $382,515 - $1.05 Million
-637,526 Reduced 98.19%
11,727 $8,000
Q3 2023

Oct 23, 2023
SELL
$1.67 - $3.33 $38,722 - $77,212
-23,187 Reduced 3.45%
649,253 $1.09 Million
Q2 2023

Jul 26, 2023
SELL
$2.83 - $4.94 $19,733 - $34,446
-6,973 Reduced 1.03%
672,440 $1.9 Million
Q1 2023

May 04, 2023
SELL
$4.89 - $12.27 $41,428 - $103,951
-8,472 Reduced 1.23%
679,413 $3.34 Million
Q4 2022

Jan 31, 2023
SELL
$8.88 - $12.77 $202,526 - $291,245
-22,807 Reduced 3.21%
687,885 $7.39 Million
Q4 2022

Jan 25, 2023
BUY
$8.88 - $12.77 $47,286 - $68,000
5,325 Added 0.75%
710,692 $0
Q3 2022

Oct 31, 2022
SELL
$8.24 - $12.56 $307,689 - $469,002
-37,341 Reduced 5.03%
705,367 $6.6 Million
Q2 2022

Aug 02, 2022
BUY
$7.45 - $13.84 $19,384 - $36,011
2,602 Added 0.35%
742,708 $6.78 Million
Q1 2022

May 05, 2022
BUY
$9.94 - $12.65 $3.55 Million - $4.52 Million
357,628 Added 93.5%
740,106 $8.99 Million
Q4 2021

Feb 02, 2022
BUY
$11.99 - $18.14 $522,236 - $790,105
43,556 Added 12.85%
382,478 $4.66 Million
Q3 2021

Oct 19, 2021
SELL
$11.55 - $16.06 $123,238 - $171,360
-10,670 Reduced 3.05%
338,922 $5.24 Million
Q2 2021

Aug 02, 2021
BUY
$12.38 - $29.19 $61,169 - $144,227
4,941 Added 1.43%
349,592 $4.99 Million
Q1 2021

May 12, 2021
SELL
$15.07 - $21.71 $428,364 - $617,106
-28,425 Reduced 7.62%
344,651 $7.48 Million
Q4 2020

Jan 26, 2021
SELL
$12.72 - $16.16 $357,152 - $453,740
-28,078 Reduced 7.0%
373,076 $5.65 Million
Q3 2020

Oct 23, 2020
SELL
$12.34 - $17.92 $147,672 - $214,448
-11,967 Reduced 2.9%
401,154 $5.11 Million
Q2 2020

Aug 14, 2020
SELL
$12.39 - $17.33 $60,091 - $84,050
-4,850 Reduced 1.16%
413,121 $7.06 Million
Q1 2020

May 13, 2020
SELL
$9.12 - $17.78 $437,112 - $852,177
-47,929 Reduced 10.29%
417,971 $5.52 Million
Q4 2019

Feb 03, 2020
BUY
$16.11 - $25.98 $1.9 Million - $3.07 Million
118,025 Added 33.93%
465,900 $7.51 Million
Q3 2019

Nov 08, 2019
BUY
$18.28 - $26.91 $6.36 Million - $9.36 Million
347,875 New
347,875 $6.36 Million

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email